Literature DB >> 16155943

Resection of recurrent pulmonary metastases in patients with osteosarcoma.

Antonio Briccoli1, Michele Rocca, Mariacristina Salone, Gaetano Bacci, Stefano Ferrari, Alba Balladelli, Mario Mercuri.   

Abstract

BACKGROUND: Surgical resection of lung metastases is widely accepted in osteosarcoma patients. Few data exist on treatment of recurrent pulmonary metastases. The authors of the current study retrospectively analyzed patients with osteosarcoma who received surgery for recurrent lung metastases.
METHODS: From 1980 to 2001, 127 metastasectomies were performed on 94 patients. Criteria of eligibility were no metastases beyond the lung, no local recurrence, possibility of achieving complete resection of metastases without causing respiratory insufficiency, acceptable operative risk. Data were statistically elaborated with survival analysis according to Kaplan-Meier method of univariate analysis, life tables and Gehan statistic model, and multivariate analysis using Cox regression test. Results were considered in terms of time from first (DFI1) and second (DFI2) metastasectomy.
RESULTS: Of 94 patients operated upon twice, 59 (62.7%) died. Thirty-five (37.3%) are alive; 31 (32.9%) of these are continuously disease-free. The 3- and 5-year event-free actuarial survival curve from first metastasectomy was 45%, and 38%, respectively, whereas from the second metastasectomy, it was 33% and 32%, respectively. According to a Cox regression model, DFI1 has a risk of death of 0.974 times and DFI2 of 0.972 times for every additional month of survival. In multivariate analysis, Cox regression test showed the best predictive model of local recurrence and number of metastases (P = 0.0014).
CONCLUSIONS: The authors concluded that patients persistently free of the primary osteosarcoma who developed recurrent resectable metastatic disease of the lung should be considered for reoperation a second, third, or fourth time, as these patients had similar DFI curves after five-years. Copyright 2005 American Cancer Society

Entities:  

Mesh:

Year:  2005        PMID: 16155943     DOI: 10.1002/cncr.21369

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  Cytotoxic efficacy of photodynamic therapy in osteosarcoma cells in vitro.

Authors:  Daniela Meier; Carmen Campanile; Sander M Botter; Walter Born; Bruno Fuchs
Journal:  J Vis Exp       Date:  2014-03-18       Impact factor: 1.355

Review 2.  Pulmonary metastasectomy: outcomes and issues according to the type of surgical resection.

Authors:  Masahiko Higashiyama; Toshiteru Tokunaga; Tomoyuki Nakagiri; Daisuke Ishida; Hidenori Kuno; Jiro Okami
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-04-03

3.  Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas.

Authors:  Jarrod D Predina; Andrew Newton; Charuhas Deshpande; Philip Low; Sunil Singhal
Journal:  J Biomed Opt       Date:  2018-01       Impact factor: 3.170

4.  Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome.

Authors:  Phillip A Letourneau; Lianchun Xiao; Matthew T Harting; Kevin P Lally; Charles S Cox; Richard J Andrassy; Andrea A Hayes-Jordan
Journal:  J Pediatr Surg       Date:  2011-07       Impact factor: 2.545

5.  Short hairpin RNA (shRNA) of type 2 interleukin-1 receptor (IL1R2) inhibits the proliferation of human osteosarcoma U-2 OS cells.

Authors:  Xiwei Liu; Li Min; Hong Duan; Rui Shi; Wenli Zhang; Song Hong; Chongqi Tu
Journal:  Med Oncol       Date:  2014-11-29       Impact factor: 3.064

Review 6.  Surgical intervention for pulmonary metastases.

Authors:  Joachim Pfannschmidt; Gerlinde Egerer; Marc Bischof; Michael Thomas; Hendrik Dienemann
Journal:  Dtsch Arztebl Int       Date:  2012-10-05       Impact factor: 5.594

7.  Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery.

Authors:  Amos H P Loh; Fariba Navid; Chong Wang; Armita Bahrami; Jianrong Wu; Michael D Neel; Bhaskar N Rao
Journal:  Ann Surg Oncol       Date:  2014-02-21       Impact factor: 5.344

8.  The metastasectomy and timing of pulmonary metastases on the outcome of osteosarcoma patients.

Authors:  Yu-Min Huang; Chun-Han Hou; Sheng-Mou Hou; Rong-Sen Yang
Journal:  Clin Med Oncol       Date:  2009-09-14

9.  Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.

Authors:  Dae-Geun Jeon; Won Seok Song; Wan Hyeong Cho; Chang-Bae Kong; Sang Hyun Cho
Journal:  Clin Orthop Relat Res       Date:  2014-02-27       Impact factor: 4.176

10.  Initial diagnostic management of pediatric bone tumors.

Authors:  Rodrigo B Interiano; Alpin D Malkan; Amos H P Loh; Nathan Hinkle; Fazal N Wahid; Armita Bahrami; Shenghua Mao; Jianrong Wu; Michael W Bishop; Michael D Neel; Robert E Gold; Bhaskar N Rao; Andrew M Davidoff; Israel Fernandez-Pineda
Journal:  J Pediatr Surg       Date:  2016-03-02       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.